LENSAR reported adjusted earnings per share of $0.31 above consensus estimates for the quarter, while revenue exceeded analyst forecasts.
The company, which specializes in laser systems for ophthalmology, did not provide specific numerical figures in its preliminary results announcement. The earnings beat and revenue outperformance were disclosed in a filing with regulators.
Analysts had expected adjusted earnings per share of $0.05, according to a survey by Refinitiv. Revenue estimates varied by source, with the company stating it surpassed the highest analyst projection.
LENSAR’s preliminary results suggest stronger-than-anticipated demand for its laser cataract surgery systems, a key product line in its ophthalmic portfolio. The company has not yet scheduled a full earnings call to discuss the results in detail.
Shares of LENSAR were not immediately active in after-hours trading following the announcement.
